Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population.

Ross-Degnan D, Simoni-Wastila L, Brown JS, Gao X, Mah C, Cosler LE, Fanning T, Gallagher P, Salzman C, Shader RI, Inui TS, Soumerai SB.

Int J Psychiatry Med. 2004;34(2):103-23.

PMID:
15387395
2.

A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders.

Simoni-Wastila L, Ross-Degnan D, Mah C, Gao X, Brown J, Cosler LE, Fanning T, Gallagher P, Salzman C, Soumerai SB.

Clin Ther. 2004 Feb;26(2):322-36.

PMID:
15038954
3.

Effects of state surveillance on new post-hospitalization benzodiazepine use.

Wagner AK, Soumerai SB, Zhang F, Mah C, Simoni-Wastila L, Cosler L, Fanning T, Gallagher P, Ross-Degnan D.

Int J Qual Health Care. 2003 Oct;15(5):423-31.

PMID:
14527986
4.

Racial disparities in access after regulatory surveillance of benzodiazepines.

Pearson SA, Soumerai S, Mah C, Zhang F, Simoni-Wastila L, Salzman C, Cosler LE, Fanning T, Gallagher P, Ross-Degnan D.

Arch Intern Med. 2006 Mar 13;166(5):572-9.

PMID:
16534046
5.

Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates.

Wagner AK, Ross-Degnan D, Gurwitz JH, Zhang F, Gilden DB, Cosler L, Soumerai SB.

Ann Intern Med. 2007 Jan 16;146(2):96-103.

PMID:
17227933
6.

Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.

Paulozzi LJ, Strickler GK, Kreiner PW, Koris CM; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.

PMID:
26469747
7.

Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations.

Weintraub M, Singh S, Byrne L, Maharaj K, Guttmacher L.

JAMA. 1991 Nov 6;266(17):2392-7.

PMID:
1681121
8.

Hypnosedative use and predictors of successful withdrawal in new patients attending a falls clinic: a retrospective, cohort study.

Joester J, Vogler CM, Chang K, Hilmer SN.

Drugs Aging. 2010 Nov 1;27(11):915-24. doi: 10.2165/11584480-000000000-00000.

PMID:
20964465
9.

An empirical review of the impact of triplicate prescription of benzodiazepines.

Schwartz HI.

Hosp Community Psychiatry. 1992 Apr;43(4):382-5. Review.

PMID:
1349557
10.

Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.

Clark RE, Xie H, Brunette MF.

J Clin Psychiatry. 2004 Feb;65(2):151-5.

PMID:
15003066
11.

Benzodiazepine dependence among multidrug users in the club scene.

Kurtz SP, Surratt HL, Levi-Minzi MA, Mooss A.

Drug Alcohol Depend. 2011 Dec 1;119(1-2):99-105. doi: 10.1016/j.drugalcdep.2011.05.036. Epub 2011 Jun 25.

12.
13.

Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in new york state.

Essock SM, Covell NH, Leckman-Westin E, Lieberman JA, Sederer LI, Kealey E, Finnerty MT.

Psychiatr Serv. 2009 Dec;60(12):1595-602. doi: 10.1176/ps.2009.60.12.1595.

PMID:
19952148
14.

Are there guidelines for the responsible prescription of benzodiazepines?

el-Guebaly N, Sareen J, Stein MB.

Can J Psychiatry. 2010 Nov;55(11):709-14. No abstract available.

PMID:
21070698
15.

Patient and facility characteristics associated with benzodiazepine prescribing for veterans with PTSD.

Lund BC, Bernardy NC, Vaughan-Sarrazin M, Alexander B, Friedman MJ.

Psychiatr Serv. 2013 Feb 1;64(2):149-55. doi: 10.1176/appi.ps.201200267.

PMID:
23154834
16.

Increased olanzapine discontinuation and health care resource utilization following a Medicaid policy change.

Signorovitch J, Birnbaum H, Ben-Hamadi R, Yu AP, Kidolezi Y, Kelley D, Phillips G, Lawson A, Ball DE.

J Clin Psychiatry. 2011 Jun;72(6):787-94. doi: 10.4088/JCP.09m05868yel. Epub 2011 Jan 25.

PMID:
21294993
17.

Examining product risk in context. Market withdrawal of zomepirac as a case study.

Ross-Degnan D, Soumerai SB, Fortess EE, Gurwitz JH.

JAMA. 1993 Oct 27;270(16):1937-42.

PMID:
8411550
18.

Has the New York State triplicate benzodiazepine prescription regulation influenced sedative-hypnotic overdoses?

Hoffman RS, Wipfler MG, Maddaloni MA, Weisman RS.

N Y State J Med. 1991 Oct;91(10):436-9.

PMID:
1684036
19.

Effect of triplicate prescription policy on benzodiazepine administration in nursing home residents.

VanHaaren AM, Lapane KL, Hughes CM.

Pharmacotherapy. 2001 Oct;21(10):1159-66.

PMID:
11601660
20.

Correlates of potentially inappropriate prescriptions of benzodiazepines among older adults: results from the ESA study.

Préville M, Bossé C, Vasiliadis HM, Voyer P, Laurier C, Berbiche D, Pérodeau G, Grenier S, Béland SG, Dionne PA, Gentil L, Moride Y.

Can J Aging. 2012 Sep;31(3):313-22. doi: 10.1017/S0714980812000232. Epub 2012 Jul 17.

PMID:
22800936

Supplemental Content

Support Center